Cloverline International Pharma Services GmbH
Country not established
- Devices
- 1
What Cloverline International Pharma Services GmbH makes
Cloverline International Pharma Services GmbH manufactures the Thixo-Gel Ultrasound Spray, a topical application device designed for ultrasound-guided administration of gels or medications through a spray mechanism.
The Thixo-Gel Ultrasound Spray is classified as a Class II medical device in the US and is listed under the FDA’s 510(k) pathway. The company is based in the United States.
Catalogue
Thixo-Gel Ultrasound Spray Ref K121311
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Cloverline International Pharma Services GmbH have in the registry?
The registry currently lists 1 device for Cloverline International Pharma Services GmbH. Devices recorded under merged duplicate company entries are counted once.
Which registries list Cloverline International Pharma Services GmbH's devices?
Among its 1 most recently registered device, Cloverline International Pharma Services GmbH has devices listed in FDA 510(k) (1 device).
What risk classes do Cloverline International Pharma Services GmbH's devices fall under?
Among its 1 most recently registered device, the classes recorded for Cloverline International Pharma Services GmbH's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Cloverline International Pharma Services GmbH in the registry?
The most recently registered devices listed for Cloverline International Pharma Services GmbH include THIXO-GEL ULTRASOUND SPRAY.